Skip to main content

New Drugs to Treat Type 2 Diabetes - 1.25 CME Credits

Start Date: Nov 20, 2018
Duration: ~ 1.25 hours
Price: $65

Course Description

Course registration is currently closed while we upgrade our learning platform with enhanced functionality and self-service options for learners. If you would like to be notified when the course re-opens in March 2020, please click here.

[This is one of seven courses in the program Trending Topics in Internal Medicine, which can be purchased together for a discount.]

New Drugs to Treat Type 2 Diabetes is a case-based review of the newer agents available for the treatment of patients with diabetes. This course focuses on the practical application of these agents for clinicians in practice, including their efficacy, cardiovascular safety and risk/side effect profiles, and when to best consider their use in clinical care.

This course is intended for primary care and specialty physicians, pharmacists, psychologists, physician assistants, nurses, and nurse practitioners.

What You'll Learn

  • Review treatment rationale and glycemic targets in type 2 diabetes (T2D)
  • Identify "new" medications for type 2 diabetes
  • Review evidence-based strategies for incorporating "new" medications in management of T2D


Florencia Halperin, MD

Florencia Halperin, MD Instructor in Medicine, Harvard Medical School; Chief of Endocrinology and Brigham and Women's Faulkner Hospital; Co-Director, Program for Weight Management, Brigham and Women’s Hospital


New Drugs to Treat Type 2 Diabetes is organized as follows:

Precourse Information:
Accreditation and AMA Credit Designation
Disclosure Statement
How to Take This Course
Viewing Videos
Grading and Certificates

New Drugs to Treat Type 2 Diabetes
Drugs Available for Treating Type 2 Diabetes: 1
Drugs Available for treating Type 2 Diabetes: 2
Case 1
Case 2

CME Certificate
CME Posttest
Course Evaluation



The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The Harvard Medical School designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Every 30 days HMS GCE will upload participant data (name, date of birth, ABIM ID#, MOC points earned) for any learners who have completed this activity directly to their transcript at the ABIM via the ACCME's Program and Activity Reporting System (PARS). Since MOC points earned will be uploaded to your ABIM transcript these points will not appear on your CME certificate. If you do not see your points on your ABIM transcript after 30 days of completing the activity please contact Jillian West at HMS GCE at


Disclosure Policy

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

Name: Louis Pasquale, MD
Role: CME Committee Member and Reviewer
Company: Bausch + Lomb
Relationship: Paid Consultant
Company: Novartis
Relationship: Non-paid consultant
Company: Allergan
Relationship: Speaker
Company: Merck
Relationship: Unrestricted Grant

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.


J. Kevin Tucker, M.D. is an associate physician at Brigham and Women’s Hospital and assistant professor of medicine at Harvard Medical School. He is also the chief of nephrology at Brigham and Women’s/Faulkner Hospital and faculty director for accreditation and MOC in the Department of Postgraduate Medical Education at Harvard Medical School. Dr. Tucker received his undergraduate education at Birmingham-Southern College and completed his medical education at Cornell University Medical College. He trained in internal medicine at Massachusetts General Hospital and in nephrology at the University of Alabama at Birmingham. His clinical interests include chronic kidney disease, hemodialysis, and peritoneal dialysis.


How long will this course take?

This course should take approximately 1.25 hours to complete. You do not need to complete it all at once. You may come back as often as you like.

How long will this course be available?

This self-paced course will close enrollments one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 11 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.